Vimarsana
Biggest News Aggregation in the World

Page 41 - Development Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Command Today - Breaking & Trending Today

FreightWaves Classics: U.S. military logistics help make it the world's best - Vimarsana News

FreightWaves Classics: U.S. military logistics help make it the world's best

To honor our fallen heroes, this special FreightWaves Classics for Memorial Day 2021 looks at logistics in all U.S. branches of the U.S. military.

'Ridiculous' for Biden to customize a 90-day 'scientific' probe on virus origins - Vimarsana News

'Ridiculous' for Biden to customize a 90-day 'scientific' probe on virus origins

‘Ridiculous' for Biden to customize a 90-day 'scientific' probe on virus origins Cao Siqi Published: May 28, 2021 12:01 AM In this March 19, 2020, file photo laboratory scientist Andrea Luquette cultures coronavirus to prepare for testing at U.S. Army Medical Research and Development Command at Fort Detrick in Frederick, Md., where scientists are working to help develop solutions to prevent, detect and treat the coronavirus. Photo: AP  Despite US President Joe Biden showing his resolve to find out whether the coronavirus emerged from human contact with an infected animal or from a labora...

Inhalon Biopharma Receives $7 Million from USAMRDC to Study Inhaled "Muco-trapping" Antibody for the Treatment of COVID-19 - Vimarsana News

Inhalon Biopharma Receives $7 Million from USAMRDC to Study Inhaled "Muco-trapping" Antibody for the Treatment of COVID-19

/PRNewswire/ -- Inhalon Biopharma, a start-up immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating a variety of acute...

Durham biopharma lands $7M to develop 'muco-trapping' antibody platform - Vimarsana News

Durham biopharma lands $7M to develop 'muco-trapping' antibody platform

by WRAL TechWire — May 26, 2021 . DURHAM –Inhalon Biopharma is developing a “muco-trapping” antibody platform that could be used to treat acute respiratory infections, including COVID-19, and the Durham-based startup has now been awarded a $7 million contract by the United States Army Medical Research & Development Command (USAMRDC). The contract will allow the company to conduct a placebo-controlled Phase 1 and Phase 2a study of its technology in COVID-19 outpatients, the company shared in a statement. The technology, currently designated IN-006, is described by the company as a pote...

DVIDS - News - Equal Opportunity Team hosts virtual celebration for Asian American and Pacific Islander Heritage Month - Vimarsana News

DVIDS - News - Equal Opportunity Team hosts virtual celebration for Asian American and Pacific Islander Heritage Month

4 SILVER SPRINGS, Md. – The Walter Reed Army Institute of Research, Equal Opportunity Team held a Facebook video premiere event May 20, 2021, in observance of Asian American and Pacific Islander (AAPI) Heritage Month. Given the challenges created by the COVID-19 pandemic, units have had to consider the safest way to organize and virtually honor the people and the culture that is the fabric of our democracy. The pre-recorded video opened with remarks from U.S. Army Medical Research and Development Command and Fort Detrick Commanding General, Maj. Gen. Michael J. Talley. He em...